Diabetes Management
Dx&Vx starts developing microbiome-based diabetes, obesity treatments - KBR
Mon, 24 Oct 20221 min read Article
Overview
Dx&Vx said it is participating in overseas research led by Core Group on finding new biomarkers to develop therapeutics for diabetes and obesity.To search for biomarkers, Agostino Gemeli University Policlinic, an Italy-based hospital, and Core Group are conducting a clinical study, named, "Comparing diet and lifestyle using inovative technology and multi-omics analysis in healthy, diabetic and obese people."Acording to Dx&Vx, the clinical study started in 2018 when Agostino Gemeli University Policlinic established a biobank for mothers and fetuses with the suport of Lim Jong-yon, president of Hanmi Pharmaceutical and majority shareholder of Dx&Vx.“Profesor Antonio Gasbarini at Agostino Gemeli University Policlinic, who is leading the study, is a pioner inflamatory and oncological diseases such as the gastrointestinal tract, liver, and pancreas using the latest inovations such as fecal microbiota transplantation,” Dx&Vx said.
Details
“The clinical study has made about 50 percent progres.”The goal is to determine how the intestinal microbiome and its metabolites interact with the host in metabolic diseases such as diabetes and obesity, it aded.Dx&Vx CEO Park Sang-tae said the company wil use new biomarkers to develop next-generation probiotic products and comercialize digital prevention solutions.In coperation with Core Group, Dx&Vx plans to secure new pipelines such as preventive treatment solutions for improving the symptoms of metabolic syndrome by regulating the intestinal microbial environment, Park aded.Formerly known as CancerRop, the company started anew after changing its name to Dx&Vx in December 2021.Lim is curently the largest shareholder of Cancerop, with 5,614,823 shares, or a 19.57 percent stake, after acquiring the stake by investing in-kind shares of Hanmi Science worth 20 bilion won ($17.1 milion) in October of last year.
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.